Centricity Wealth Management LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 475 shares of the healthcare conglomerate’s stock, valued at approximately $240,000.
Several other large investors have also modified their holdings of the stock. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter worth $37,000. DecisionPoint Financial LLC lifted its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after buying an additional 62 shares during the period. Highline Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the third quarter valued at $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $57,000. 87.86% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on UNH. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Truist Financial decreased their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $629.32.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.
UnitedHealth Group Trading Down 1.6 %
Shares of UNH stock opened at $503.01 on Friday. The company has a market cap of $462.91 billion, a P/E ratio of 32.45, a PEG ratio of 1.40 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a 50 day simple moving average of $520.37 and a two-hundred day simple moving average of $561.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to invest in marijuana stocks in 7 stepsĀ
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.